United States 2026 · Every advertiser
RunawayRx
This page ran 3 paid political ads on Facebook and Instagram between 14 September 2026 and 14 September 2026. Meta reports $100 – $397 of spend, which makes it the 19,414th largest advertiser of the 24,034 pages in our data. Advertiser type: Group or campaign. Most of its spend took no side. Race: No specific race. Paid for by California Association of Health Plans.
Data from the Meta Ad Library, pulled 4 November 2026. Election on 3 November 2026. · Every ad of this page in Meta’s Ad Library ↗
3
ads
$249
reported spend, range $100 – $397
0.0%
of spend on federal races
$50
median spend per ad
Spend by week the ad started
Tone
Share of the 3 ads with text that our model classified. Attack ads name an opponent.
Most attacked
- the Alzheimer's Association$150
- AB 1887$50
Targets as the ads name them, by spend; the spellings of Donald Trump are counted together, other names as written.
Topics
Spend by race: State 20%, No specific race 80%.
Spend by ad language: English 100%.
The costliest ads
The highest-spend ad of each distinct text, as it ran.
SB 950 would mandate coverage of brand-name drugs for Alzheimer’s disease and related dementias. The bill is sponsored by the Alzheimer’s Association, which disclosed more than $7 million in large pharmaceutical contributions in 2025 — including from manufacturers of Alzheimer’s drugs. When drugmakers stand to benefit from new coverage mandates, Californians deserve to know who is behind them — and who ultimately pays. Governor Newsom: Veto SB 950.
14 September 2026 · RunawayRx · $100 – $199 · 45K+ impressions · Attack · Ad Library
Prior authorization is one of the tools health plans use to manage prescription drug costs and help keep premiums affordable. AB 1843 would restrict the use of prior authorization for certain medications, removing an important check on rising drug costs. California needs policies that put downward pressure on health care costs, not policies that remove tools used to improve affordability. Governor Newsom should veto AB 1843.
14 September 2026 · RunawayRx · $0 – $99 · 6K+ impressions · Attack · Ad Library
Follow the money on AB 1887. AB 1887 would eliminate prior authorization and step therapy for certain high-cost rare disease drugs — tools that help manage prescription drug costs and keep premiums affordable. The bill is backed by advocacy organizations with financial ties to pharmaceutical manufacturers. Who benefits? Drugmakers. Who pays? Californians, through higher drug costs that drive higher health care premiums. Governor Newsom: Veto AB 1887
14 September 2026 · RunawayRx · $0 – $99 · 8K+ impressions · Attack · Ad Library
Figures cover domestic political ads paid in dollars, from 4 May 2026. Spend is the sum of Meta’s range midpoints; impressions above one million are reported as “1M+”, so impression figures are floors. Each ad counts in the week its delivery started, with its lifetime spend at our last pull; ads still running before the vote are counted as of 31 October 2026.
Back to the United States report, both parties and every candidate or every advertiser.